ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 202

Bone Accrual in the Dnase II-Deficient Model of Autoimmunity Requires Sting, As Well As Hematopoietic and Stromal Elements

Rebecca Baum1, Shruti Sharma1, Ann Marshak-Rothstein1, Katherine A. Fitzgerald1 and Ellen M. Gravallese2, 1Medicine, University of Massachusetts Medical School, Worcester, MA, 2Lazare Research Bldg Ste 223, University of Massachusetts Medical School, Worcester, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: autoimmune diseases, Bone, DNA, inflammation and osteoblasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Innate Immunity and Rheumatic Disease Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: We have previously identified a role for cytosolic DNA sensors in bone by analyzing mice that develop inflammatory polyarthritis and trabecular bone accrual in the setting of DNA accumulation. In this model, DNA accrues in macrophages due to deletion of DNase II and is detected by cytosolic sensors that signal through stimulator of interferon genes (STING). This results in inflammatory cytokine and Type I IFN production. Type I IFNs in DNase II-/-mice lead to anemia-driven embryonic lethality; thus co-deletion of the type I IFNR is essential (DNase II/IFN-IR double deficient (DKO) mouse). Although macrophages are implicated as a critical cell type in this model, new evidence suggests that a stromal component also plays an important role in the observed bone phenotype.

Methods: Histologic analysis of long bones was performed to confirm phenotypes. Macrophages were expanded from bone marrow (BM) of wild type (WT) and STING-deficient mice, transfected with poly(dA:dT) and RNA was analyzed by Nanostring using probe sets for genes in both innate immune and bone-related pathways. RNA was also prepared from whole BM from control and DKO mice, and similar Nanostring analyses were performed. We utilized bone marrow chimeras to determine the contribution of hematopoietic vs. radioresistant host cells to the bone phenotype. Lethally irradiated Het (DNase II+/- IFNaR-/-) or DKO mice were reconstituted with Het or DKO stem cells to generate four groups: Het (donor)→Het (recipient), DKO→DKO, Het→DKO and DKO→Het.  Complete reconstitution was verified by FACS analysis.

Results: As previously reported (A&R 2014; Vol 66:11S, 788), we found that trabecular bone accumulates in long bone and spleen in DKO mice, two sites of DNA accrual in macrophages. MicroCT, CFU assays for osteoblast precursors, and histomorphometry all supported a predominant role for osteoblasts in this bone phenotype. We showed that STING deficiency abrogated both arthritis and bone accrual in DKO mice. We now show that in total BM from DKO mice, expression of STING itself as well as of Ifi204, a cytosolic DNA sensor in the STING pathway, is up-regulated. BM-derived macrophages were prepared from WT and STING-deficient mice and transfected with poly(dA:dT), resulting in a trend toward up-regulated expression of genes known to promote osteoblast differentiation. STING deficiency abrogates up-regulated expression of these genes. Finally, analysis of bone marrow chimeras demonstrated that only DKO→DKO mice developed trabecular bone accrual, demonstrating that both hematopoeitic and stromal elements are required for expression of the bone phenotype.

Conclusion: Trabecular bone accrual is a feature of the autoimmune DKO mouse model. We have identified candidate factors that may drive osteoblast differentiation and function in this model, the expression of which depend on STING. Furthermore, macrophages contribute to the bone phenotype. However, bone marrow chimeras demonstrate that both hematopoietic and stromal elements are required. Identification of novel pathways linking innate immunity and bone may allow for new targets to treat bone loss in autoimmune disease.


Disclosure: R. Baum, None; S. Sharma, None; A. Marshak-Rothstein, None; K. A. Fitzgerald, None; E. M. Gravallese, None.

To cite this abstract in AMA style:

Baum R, Sharma S, Marshak-Rothstein A, Fitzgerald KA, Gravallese EM. Bone Accrual in the Dnase II-Deficient Model of Autoimmunity Requires Sting, As Well As Hematopoietic and Stromal Elements [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/bone-accrual-in-the-dnase-ii-deficient-model-of-autoimmunity-requires-sting-as-well-as-hematopoietic-and-stromal-elements/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-accrual-in-the-dnase-ii-deficient-model-of-autoimmunity-requires-sting-as-well-as-hematopoietic-and-stromal-elements/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology